Antimicrobial Susceptibility Testing Market worth 3.47 Billion USD by 2022

From: Marketsandmarkets
Published: Fri Sep 07 2018


Factors such as increasing prevalence of infectious diseases across the globe, emergence of antimicrobial resistance caused due to drug overuse, increasing initiatives by government organizations towards improving the detection and control antimicrobial resistant species, and improving growth opportunities in emerging markets are boosting the demand for antimicrobial susceptibility testing products.

"The global antimicrobial susceptibility testing market is expected to reach USD 3.47 Billion by 2022 from USD 2.71 Billion in 2017, at a CAGR of 5.1%."

Browse 62 market data Tables and 38 Figures spread through 164 Pages and in-depth TOC on "Antimicrobial Susceptibility Testing Market "
https://www.marketsandmarkets.com/Market-Reports/antimicrobial-susceptibility-testing-market-206359984.html<\strong>

Antimicrobial susceptibility testing (AST) market by product, method, type, application, end user, and region.

By method, the market is segmented into disk diffusion, dilution, ETEST, automated susceptibility testing, and genotypic methods. Growth in this segment can largely be attributed to its low cost and the flexible nature of these methods.

By product, the global market is segmented into automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables. The manual susceptibility testing products segment is expected to command the largest share of the global AST market in 2017. This is attributed to factors such as the rising prevalence of infectious diseases leading to an increased demand for susceptibility testing products and benefits such as low cost and the ease of use of these products.

FREE Brochure @
https://www.marketsandmarkets.com/pdfdownload.asp?id=206359984<\strong>

By application, the global market is segmented into clinical diagnostics, drug discovery and development, epidemiology, and other applications. The other applications segment includes veterinary diagnostics, bioterrorism surveillance, and environmental monitoring. The clinical diagnostics segment accounted for the largest share in 2017. A number of factors such as the increasing prevalence of infectious diseases, the rising burden of antimicrobial resistance, and growing awareness about the use of antimicrobial susceptibility testing methods for diagnostic applications are responsible for the large market share of this application segment
.
On the basis of end users, the global AST market is segmented into diagnostic laboratories and hospitals; pharmaceutical and biotechnology companies; contract research organizations; and research and academic institutes. The hospitals and diagnostic laboratories segment is estimated to command the largest share of the antimicrobial susceptibility testing market in 2017. Some of the factors driving the growth of this segment are the increasing prevalence of infectious diseases, increasing healthcare expenditure, and the increasing number of initiatives towards better antibiotic use.
Company: Marketsandmarkets
Contact Name: 1marketsandmarkets
Contact Email: debashish.roy@marketsandmarkets.com
Contact Phone: 1-888-600-6441

Visit website »